Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All hype and nonsense. This is a supplement company. Walk into GNC, Whole Foods, CVS, your local Hay n Feed store.
Look at AAAALLLLLLLLL the products on the shelves with similar ingredients that claim to do the same thing. Then, notice there are zero Bio products on those shelves. Stupid investment. Pumper stock scam. 1 plus 1 equals 2 unless you find yourself in pumperland on a public stock board.
Ok, I have to ask you a very direct question. This company has no money. Zero. Tons of debt. Please explain where they get 1) an underwriter to pitch these worthless (non-existent) LiveStock shares, and 2) the money to pay said underwriter?
I may be wrong, but it sounds like you are part of a stock crew that misuses words like "spinoff" in cahoots with a BS press release on the OTC to keep a stock scam propped up. This was no real spinoff. It's just a move to separate a small little business between human products and animal products. Just like the super water MORO2, Inc. is a separate company (and equally worthless). It is meaningless. LiveStock has zero shares and will never have any shares. It's ALWAYS been a division of Bio. Always. Now it's just a wholly-owned subsidiary. Nothing special. No new shares. Underwriter???
I'm not trying to be mean but you do understand that 99% of folks who actively trade on the OTC absolutely KNOW charts are meaningless. Like swear on their first-born child KNOW. But you do you!
This echo chamber is like a row of ostriches with heads in the sand. It's also like a MAGA fake news rally. Clear words from press releases, coupled with clear words from the company's public filings get distorted to match a nonsense agenda. Here is the original PR from April with the future tense, going to spin off, as an intention:
https://finance.yahoo.com/news/bioadaptives-inc-announces-intention-spin-120000265.html
Next is the September 8 PR with the present tense plain English use of the word "announces" BioAdaptives, Inc. Announces the Spin-off:
https://finance.yahoo.com/news/bioadaptives-inc-announces-spin-off-120000935.html
Let's all read together......"BioAdaptives, Inc. (OTCMkts: BDPT) announced today the spin-off of its LiveStock Impact Division as a wholly owned subsidiary."
That was the announcement. Done Deal! Spinoff complete with the identification of new management and directors. Plain English!
Then, a few days later, they announced the appointment of two additional directors to the new company that was already spun off days earlier:
https://finance.yahoo.com/news/livestock-impact-inc-wholly-owned-120000994.html
Don't worry, I will check in on the first of every month to ask where the spinoff shares are. It will be fun.
As long as we can agree that in the real world of public companies, fiduciary duties, material disclosures, that BDPT would need to provide the good doctor with fair compensation for any such use, well, nope, not that far-fetched at all.
That's entirely different than some internet shyster saying BDPT has these patents and claiming the company is severely undervalued. Would you agree?
I understand completely. It's also very obvious when you look at one-year charts to see a pump and dump. A picture is worth a thousand words:
https://www.marketwatch.com/investing/stock/bdpt?mod=search_symbol
BDPT is in the dump phase. Since the company publicly announced plans for more dilution, the only hope for a run is pumpers like PB and his crew who peddle nonsense. Are you honorable enough to step up and tell the class that the bully PB is wrong and the LiveStock spinoff is already complete, with zero new IPO shares magically coming to investors? Or do you just take pithy shots from the sidelines?
Nah, what is strange is the cult following of the BS posted about these companies. Here is the actual website for LiveStock Impact, Inc.
https://livestockimpact.com/about-livestockimpact-inc/
The company very clearly lists itself as a wholly-owned subsidiary of BioAdaptives, Inc. It does not say it is going to be a company. It is a company. It has management. And it has a Board of Directors. Same guys as BioAdaptives. The guys are listed on the website. Click the Investors tab. They say great things about themselves and each other. It's all wonderful and out there for public consumption. Just like the last BDPT quarterly report that disclosed a $9,000 wholesale order that was double anything from the past. It's all there for anyone to read. And your point is........
I don't care if you invested money in this turd and lost. Heck, it's dirt cheap again so you're free to buy more. Average down and rely on that PB pump machine. Good Luck!!
The only person who twists your words is you. This is EXACTLY what you told folks:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172143592
I am 100% correct about the completion of the spinoff. It's done. It's one dude who runs a ranch in Oklahoma who struck a deal with an online company to market and sell the stuff while he uses it for his own horses and tells all of his buddies how great the product is, begging them to buy it also. Not rocket science. The sales are already reported on the last quarterly report. $9,000 for the past 6 months which is more than double the prior period. IT'S A DONE DEAL!!!!!!!
But spin away Lyin' Lion.......
He's a director. He probably owns a house, a few cars, maybe a boat. Are you suggesting those assets of his are somehow the assets of BDPT now since his is on the Board? I'm not trying to be rude since I'm not sure the tone of your question. I will be direct. Those patents are owned by him and his business, not by BDPT.
Are you capable of telling the truth? This is a marketing company with hardly any employees. They say it directly in their own public filings. The spinoff of LiveStock was a very simple move to separate the animal business from the human business. There was nothing to do. There is no magic corporate hocus pocus going on behind the scenes while BDPT registers new shares of LiveStock. All they did was create a wholly-owned subsidiary with the newly identified management team. LiveStock is still under the BioAdaptives umbrella. This is such basic stuff.
"Employees: The Company currently has 3 executive employees and 3 part-time employees. We retain hourly labor on an as-needed basis and professional consultants to operate our business. The management of the Company expects to continue to use outside consultants, attorneys, and accountants, as necessary, as long as it is seeking and evaluating business opportunities. The need for additional employees, and their availability, will be addressed in connection with the decision whether or not to acquire or participate in specific business opportunities."
You act like this is some huge conglomerate when clearly it is not. All of this information is in the public filings.
Read the last quarterly report:
https://www.otcmarkets.com/filing/html?id=16857401&guid=jt5-k6EIXgLldth
Here is a quote about what actually happened with LiveStock:
"Our [one needs to understand the basic concept that "our" refers to BioAdaptive's ownership/licensing] animal products include an Equine All-in-One™ and Equine All-In-One Plus™ formulation, which we ["we" meaning our wholly-owned subsidiary called LiveStock] market to trainers, horse owners and boarding stables, and a Canine All-in-One™ that we [get it yet?] market directly to consumers. Anecdotal and testimonial reports are that the equine products provide significant relief from exercise induced pulmonary hemorrhaging, as well as improved coat and mane appearance and hoof health. The canine products have demonstrated significant rejuvenating benefits for older dogs, improving overall appearance and energy levels. Effective April 2023, FBRTherapy Division has been appointed its exclusive Distributor for all LiveStock Impact’s products, as such The Company also negotiated with the supplier for the exclusive marketing rights to these products from the non-exclusive license it has held since June 2022."
The LiveStock products are clearly identified as the horse and dog products. FBRTherapy Division now sells the products on behalf of LiveStock, with the money being allocated and reported on the BioAdaptives quarterly report. So, let's get something straight. There is no crazy complicated business divestment or synergy psychobabble BS going on. LiveStock isn't even doing anything to sell the horse and dog products anymore. They licensed out the sales efforts to FBRTherapy. And when sales are actually made, guess what??? BDPT reports the revenues on its quarterly report:
"Since the appointment of FCBTherapy as its exclusive Distributor, LiveStock impact is withdrawing from its own websale and is encouraged with the first initial wholesale order from FCBTherapy is over $9000 which is double the last 6 months gross sales."
So, to recap, LiveStock doesn't do anything anymore except collect money from sales made by FCBTherapy. And that money is then reported as an asset on the BDPT balance sheet. THERE WILL BE NO MAGICAL IPO SPINOFF SHARES!!!!!!!!!!!!
Just read what the company itself actually says about it's equine business:
"With regard to animal products, the Company’s Livestock Impact Division under the direction its President, Bruce Colclasure, a National Cutting Horse Association champion, who owns and operates the Flying C Bar Ranch in Oklahoma and a breeder and trainer of over 80 NCHA champion cutting horses, continues to explore new opportunities in this emerging market. Mr. Colclasure uses and endorses our Equine All-in-One™ and derivative booster products providing valuable feedback and testimonials regarding their benefits. In addition, a high-performance special formulation of our All-in-One product continues to be marketed with exceptional results. We expect to expand the outreach in 2023.
In light of the failures of our past social media campaigns, we recommenced a social media effort this quarter with better response. The Company continues its marketing affiliate outreach program for the equine products, directly contacting the principals of horse clubs and associations, offering discounts, samples and other inducements, seeking to develop “product champion” and “maven” relationships. We contacted principals in organizations with thousands of members and many more thousands of horses. Since the 4th Quarter 2022, we have been distributing samples and marketing materials to over 40 principals and influencers in regional and breed-specific equine associations and in anticipation of receiving feedback from these marketing initiatives in 2023."
It is plain English. The guy who now runs LiveStock is a ranch owner, breeder and trainer in Oklahoma. He uses the products for his horses. He thinks they are great. The big upcoming plan is to give discounts, free samples, heck beg other breeders and trainers to use the supplements on their horses to get anecdotal feedback so they can hopefully actually sell some snake-oil. Goodness, it does not get any more clear from the horse's mouth (sorry, couldn't resist!)
You can pump nonsense all you want but anyone can read exactly what the company says about itself:
"Because our business plan relies on marketing products we license from others, our capital requirements are generally limited to general operations and administration, including the costs of continuing as a public company, and our variable costs scale up or down based on our actual sales. We believe that increasing our marketing expenses will be critical to establishing sales sufficient to cover our expenses and, if possible, generate a profit. We anticipate using our existing financing operations to do so, which will almost certainly require either the issuance of equity or increases in existing levels of debt or, most likely, both.
Management’s plans include the raising of capital through the equity markets to fund future operations, seeking additional acquisitions, and generating revenue through our business. However, even if we do raise sufficient capital to support our operating expenses and generate adequate revenues, there can be no assurances that the revenue will be sufficient to enable us to develop business to a level where we will generate profits and positive cash flows from operations. These matters raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty."
Bet you wish you would have sold at .005, yes?????
Let's have some fun on a Friday when BDPT hit trips again. We will take a trip down the Lyin' Lion Memory Lane:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172135554
BDPT has NEVER listed a $570,000,000 MILLION DOLLAR PATENT on its balance sheet. Absolute Lie!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172140082
Yup, he actually posted the LiveStock division is much bigger than we think. Can't make this up. $9k order as their biggest sale ever. YUUUUUUUGGGGEEEEE!!!!!!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172142759
June 15, 2023, starts pumping the spinoff as some IPO that will make folks rich. That was over 4 months ago, has been proven 100% inaccurate, but still posts the same nonsense.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172143592
Now the lie increases to patents worth $780m. BioAdaptives has never, ever, ever owned any patents worth $780m. But this person copies and replies to his posts on multiple boards over and over to push a lie that scams innocent people. Oh, and then there is the ongoing promise of riches if one just holds and waits for the.....wait for it....it's coming.....any day now.....SPINOFF IPO SHARES!!!!!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172383956
Let's fast forward a month to the end of July to see how the pump continues.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172419782
Scamming his followers to hold tight and never sell!!!!!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172431106
Hearing this guy comment on scammers is HILARIOUS!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172476312
Love it when he posts targets that age like fine prunes.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172506516
He actually admits to concerted effort to drive the price higher. Hello, anyone from the SEC out there???
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172524643
This post about BDPT and its management is beyond comment. Just read it all and take it in! Then read the actual filings to understand this is merely a marketing company that pushes non-FDA regulated supplements. No billion dollar patents. No pipeline. Nothing, Nada, Zilch!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172549043
Now he's pumping how great the products are because he uses them. Can't make this stuff up!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172549043
Oh, I'm sure many have regrets following this shyster.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172546246
Translation: I'm holding bags, am not a flipper, keep buying more of this gem at higher and higher prices, because payoff and riches will come at pennies. Ummmmmm riiiiiggggghhhhttttttt
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172546513
Anyone who posts buys like this should accept the consequences of being called out.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172557766
Wrong, wrong, wrong. Always wrong.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172557766
The classic get in before it's tooooooooo late post. Love it!!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172575064
Confirms he did not sell at the peak. WHOOOOPS!!!!! But don't worry, when he defends his trading acumen, he lies and says he scalped profits all along. While shaming everyone else for being fliptards. He's such a gem!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172575221
Shameless lies, lies, lies. No $780m in patents. No spinoff shares. Not undervalued in any way, shape or form. Anyone else sick to their stomach yet?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172582863
Just take this one in!!!! Missed out on major profits, but ridicules someone else. Par for the course.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172589210
Multiple pennies?!?! It's back down to trips. This could go on all day. Anyone can read this person's nearly 100,000 posts. Think about that. Soooooooo many posts all trying to manipulate the market.
Just remember.....no billion dollar patents.....no free spinoff shares......very little revenues......massive debt......can only raise money by diluting with more shares......no pennyland in sight......holistic vitamins and supplements where anyone can pitch an unregulated product and try to sell as much snake-oil as they can.....problem is BDPT sucks at selling snake-oil. Maybe they should hire PB?????
Someone please sticky this post. If not, it's #19504. I propose the 1st of every month as BDPT Spinoff Shares Day! Reply to this "wise" post and ask, "Where are my free spinoff shares???"
The more you post, the clearer it becomes you know nothing about public companies. It's wonderful so all can see. For me,it's like dealing with a child because it's so easy to win any argument with facts.
A wholly-owned subsidiary is the concept you fail to understand.
https://www.investopedia.com/terms/w/whollyownedsubsidiary.asp
LiveStock was an existing division that was spun off as a wholly-owned subsidiary. By definition, 100% of its stock is owned by the parent company, BioAdaptives. LiveStock has its own management now, but it is reported on the books of BioAdaptives. There is no separate stock that is owned by you or anyone. Why? C'mon kiddo, you can grasp this concept. Because LiveStock is 100% wholly.....owned.....by.....BioAdaptives!!!!
Keep posting your ignorance and lies. Anyone who believes your false claim that they will get new shares or dividends or any compensation whatsoever as a result of that spinoff that occurred months ago deserves what they get. Nothing.
LiveStock was previously on the books and accounted for less than $10k in revenues before. Now, as a spinoff, BioAdaptives already reported LiveStock had a $9k wholesale order which was more than double the last 6 months revenue. Bio reported that because LiveStock is reported on the Bio books. Just like it was before the spinoff. Simple concept.
All of your posts (yes anyone can check) saying you are here for the spinoff, waiting for the spinoff, waiting for new shares, blah blah blah, prove you don't understand. The spinoff is done.no new shares. 100% owned by Bio. Counted on tbe Bio books like before. Naptime kiddo.
It's a public board so I can reply as I wish. The company has been public for over 10 years in the same sector. You see a hidden gem and I see a failure with a proven track record of failure. We can agree to disagree.
Here's where you lie and refuse to take responsibility when I expose you. I can copy links to post after post from you lying to these folks about the spinoff and false claims of dividends and new shares. I proved it to everyone but you cannot admit it. You refuse even when it's so clear. Just say it to everyone. Admit you were wrong about the spinoff being a source of future riches for shareholders. Admit you "misunderstood" and you got that wrong. Admit what everyone already knows and I will consider no longer replying to your BS lying posts. Deal?
There's no danger in shorting what PB pumps. It's a tried and true trading strategy.
I know, people without enough money or knowledge don't know how to short pinkies. Poor folks say that all the time. Don't worry about me LOL
IMO you are in danger of being publicly destroyed if you continue down this path with me. Do you read public filings? Do you know what public filings are? Do you know public companies have a fiduciary duty to not make material misrepresentations to investors? Do you understand BDPT accurately exposes its warts in its public filings? Do you accept you only have yourself to blame if you invest in a crappy company that actually tells you how crappy it is in its public filings? Do you know when you're overrmatched or will you display a big set of internet huevos and argue nonsense with no factual backup? Do you know anything at all about BDPT other than what some pumpers post on ihub?
Sorry you are afraid of facts. Let's get this straight. Your position is that the company announced a 2 year licensing agreement to its public shareholders, but never closed the deal? That's what it sounds like you're claiming. Can you back that claim up with the public filings? I can show you the truth if you're interested and not too afraid.
"Effective February 2, 2022, the Company acquired the option to purchase U.S. Patent No. 9,783,432B (the “Patent”), covering technology used in enhancing the capability of water to hold significantly larger amounts of oxygen. Since June 6, 2022, we entered into a services agreement with Wildpack Beverages in Las Vegas, Nevada to co-pack a pilot run (1333 cases) of this Product. However, since technical problems prevented completion of the planned pilot run, we are still working to rectify these issues and explore how to deploy the technology." Ummmmm, pathetic.
How about this nugget from the last public quarterly report:
"During July and early August, The REG A filed and as amended in November 2022 for 200,000,000 common shares at $0.001 were fully subscribed. This provides the Company with the liquidity to pursue further research into its lead products: Pluripain® , SleepEZ™ and Primilungs™ and move the Company’s testing, development and marketing programs forward. The Company is also in discussion with marketing specialists in expanding its footprint on the Amazon market place now that the RegA has been fully subscribed and provide the necessary funding for more intensive marketing efforts. Since the appointment of FCBTherapy as its exclusive Distributor, LiveStock impact is withdrawing from its own websale and is encouraged with the first initial wholesale order from FCBTherapy is over $9000 which is double the last 6 months gross sales."
You understand that, yes? They got a HUGE wholesale order of $9,000 for their equine products. And that was DOUBLE what they made in the past 6 months! How this company has a market cap over $50,000 is the true mystery.
Let's try this. You seem very wise and an experienced investor. Can you help explain this public company statement from the quarterly report with your analysis why BDPT is a great investment:
"Since the latter part of March, the Company has started to explore the Botanical Drugs sphere. We acquires the non exclusive licenses from Dr. Yaguang Liu, LY Research for Glucose Management, Eye Health due to Myopia and Presbyopia and a resveratrol product. Dr Liu has had over 40 years of research and development in the Botanical Drugs area. We are exploring the opportunities in deploying these patented products for nutraceutical use for human and animal initially.
While we continue to investigate and acquire nutraceutical products for humans and animals, all of our current activities are reliant on marketing and distributing products developed and owned by others. Currently, other than the two equine formulations where we have the exclusive marketing rights, we do not own the formulations for our key products and manufacture and market them under an agreement with the developer that requires payment of a royalty and a license agreement. We are negotiating towards the acquisition of some of these formulations.
We are reliant on direct web sales of the nutraceutical lines for humans and the All-in-One animal products for revenues, none of which has produced any significant revenue yet. Because of this, we are now exploring the wholesale and affiliate markets for their sales. We have very limited experience in marketing and have yet to develop reliable sales expectations and forecasting."
C'mon, don't worry about fear(mongering). Help us understand.
You have it backwards. If you want an echo chamber to pump each other up about your "awesome" BDPT investment, start a private Discord channel.
If you have something relevant to say on ihub about whether the company is a good or bad investment or trading opportunity with actual facts, common sense and public filings, keep posting here.
You do realize this is a holistic vitamin/supplement company, yes? With meaningless sales, yes? Their own filings clearly state they are just a marketing company. You read and understand that, yes?
Sounds like a paid BDPT snake-oil salesmen. Even this supplement company with paltry sales knows to follow the FDA rules with the proper disclaimer in the PR:
"None of the statements about the Company’s products have been approved by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease."
But, but, but, if you get your medical information from some pumper on the interwebs, you can find cures to all medical ailments on the OTC stinky pinkies! The ancient Chinese herbs that make this product didn't cure insomnia. Or the lemon balm. But, once BioAdaptives combined them together with other "proprietary" ingredients, BOOM the gazillion dollar insomnia market has been cracked and BDPT shareholders are going to be rich because they got in on the ground floor. The American Dream!! The pharma companies are so stupid pouring billions into R&D with clinical studies to get FDA approval. You only need to spend $7m over 10 years to combine some natural weeds and herbs until BOOM insomnia is solved.
Thank you PB for bringing this incredible gem to everyone's attention. Find us the cure for cancer next please.....and do us a favor by pumping it BEFORE it spikes and you come in after with your megaphone of nonsense.
The company sales speak for themselves. They only had $6k in revenues in 6 months. If you are comfortable investing in such a company, I'm not here to tell you no. Just do yourself a favor. Go to the BioAdaprives website and view their products page. That's the entire lineup.
Then go to the LiveStock website. That products page is empty. No one can buy the equine/pet products from the company. Check it out for yourself.
This is a vitamin/supplement company with hundreds of competing products in every holistic store around. But they are purely online with paltry sales. It's snake-oil with online stock pumpers who created an artificial spike from June to October. The next round of dilution killed the party, but since some of the crew got caught with their pants down touting pennies and nickels, the falsehood pump continues. Sorry if you got duped.
Folks should understand the history of this character. After a stock starts a run, is the biggest pumper of the company and then creates a false narrative to generate artificial excitement. There is a whole crew that then comes aboard for the echo chamber. For BDPT, it was the false claim that the "spinoff" was going to result in an IPO with new shares in a new company. This has been repeatedly shouted since June 2023, and still to this day keeps spreading the exact same nonsense.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172142759
THERE WILL NOT BE A SEPARATELY TRADED COMPANY!!!!!!!! The same BS has been spread since June and it is simply not going to happen. The press releases very clearly explained that this spinoff is in the form of a wholly-owned subsidiary. That means no new ticker, no dividend distribution, nothing of the sort. The huge spike in June carried on like a wave for a few months and now it is trickling back down to reality.
Here's the absolutely fascinating thing about this person. When he gets in early on some pump like BDPT, he cannot help himself from buying more on the way up. Then he gets caught with the eventual bag when the stock nosedives. It happens repeatedly because pigs get fed and hogs get slaughtered. Then, anyone who dares to disagree with the incorrect "DD" gets called all sorts of names by him and the crew. Just watch.
The spinoff is a nothing-burger. It happened months ago. It's still on the company books and the August 10Q confirms it. The company has virtually no assets. Read the financials. No patents worth hundreds of millions. Just fantasy BS that all started on June 13 and continues to this day because got caught with bags once again. Pathetic!
It helps to actually read, and then actually understand the press releases and public filings. Let's start with the spinoff. Here is the truth. LiveStock Impact, Inc. is a wholly-owned subsidiary of BioAdaptives, Inc. While it is true that LiveStock is a "new" company with its own corporate governance, it is not a separately traded public company. It is a wholly-owned subsidiary and therefore still counts on the books of BioAdaptives, Inc. Anyone can read the press releases from August and September 2023, which explain what happened with this spinoff accurately. There will be no magic new shares worth some magic new amount of money. Absolute gibberish. Read the company's own press releases:
"LiveStock Impact, Inc. will continue with the development and distribution of health and wellness products unique for animals. Presently, products for canine and equine users provide for improved appearance and general health as well as rejuvenating the animal for overall performance. The new company will continue its efforts beginning as an operating division of BioAdaptives, Inc., but, as a wholly-owned subsidiary, will gain the corporate independence to explore new alliances, develop new markets and products, and consider new and unique solutions for growth and expansion. The new Company will continue to rely upon past science and nutrition advisors to assist in product and formulation decisions."
That is plain English and explains the situation perfectly without some internet shenanigans spreading malarkey. Yes, it is a "spinoff" and a "new" company, and yes it is ALSO still a 100% wholly-owned subsidiary of BDPT. Anyone who claims otherwise should not be trusted for stock analysis.
Let's turn to the "super water" patent. Let's actually read the public company 8K filing to understand exactly what was purchased and, more importantly, for how long:
https://www.otcmarkets.com/filing/html?id=15529463&guid=Rt5-knujO07-B3h
"Effective February 2, 2022, the Company entered into a Patent Purchase Agreement and Consulting Agreement with Thomas J. Mohr. Under the Agreement, the Company has the exclusive option to purchase Mohr’s U.S. Patent No. 9,783,432B (the “Patent”), which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen, for a two-year period. The option price is $400,000. The Agreement furthermore allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. In exchange for the license, the Company will pay Mohr a royalty, scaled to total product sales.
The Agreement also calls for Mohr to provide consultant/inventor services to the Company during the option period, which may include establishing a research laboratory and prototype manufacturing facility. Among other things, Mohr will assist the Company in developing additional consumer products using the oxygenation technology and provide technical services for manufacture, installation, and use of production machinery. Mohr will be paid a monthly cash stipend. In addition, Mohr allows the Company rights as to inventions created during the Agreement.
The Company will exploit the Patent and Mohr’s consulting services through a newly established wholly-owned subsidiary, MORO2, Inc."
Let's unpack that, shall we. It is a 2-year licensing agreement. It cost $400,000. Mohr is paid an additional monthly stipend. Fancy water has been "sold" now for 20 months, with only 4 months left to go before the license expires. The company has not made anywhere close to $400,000 in sales to recoup this FANTASTIC investment. Just another cash bleed which has me convinced that this BDPT company is just a tax write-off for a wealthy doctor who makes his real money in other ventures. Anyone can search online for this magic oxygen water under the MORO2 label to understand exactly why there are no sales. There is no product. BioAdaptives does not even sell this super oxegenated water on its own website. MORO2 has no website. And once again, MORO2, Inc. is a wholly-owned subsidiary of BioAdaptives, Inc. just like LiveStock Impact, Inc. is a wholly-owned subsidiary. No new shares, no new ticker, no separate company off the BDPT books with its own value. Nope! Just like LiveStock, it is another little shell game PR gimmick to give folks the impression that this BDPT company is going places, baby! That's the TRUTH because the person "executing" this business plan with such pathetic revenues should probably be executed. But maybe someone here on the interwebs knows more than the rest of us.....
Since the world of "ifs" is in play so as not to be "clueless" perhaps try this one on for size. If the company does not sell anything to make money, and if the company continues to accumulate debt, then the company will likely issue more stock to fund operations which will dilute current shareholders further and will depress the stock price. Fair speculation or clueless? A reasonable person would say fair, yes? From the last quarterly report:
Total Assets $48,273
Total Liabilities $1,726,785
Total Stockholders' Deficit $1,678,512
That is not healthy
6-Month Revenues $5,715 (I checked to see if that was noted in millions.....nope, just under 6 grand)
6-Month Net Loss $431,104 (This is called bleeding cash)
One can either get their company information from "investors" on a public board, or one can read what the company actually says about itself to shareholders in its own public filings:
"The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses since inception and had an accumulated deficit of $7,982,783 as of June 30, 2023. The Company requires capital for its contemplated operational and marketing activities. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. Obtaining additional financing, successful development of the Company’s contemplated plan of operations, and the transition, ultimately, to profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.
In order to mitigate the risk related with this uncertainty, the Company plans to issue additional shares of common stock for cash and services during the next 12 months."
Back in days of yore, there were folks called snake-oil salesmen. They went from town to town to tout the latest and greatest tonic, potion, doo-dad that would heal all ills and make every human thrive. Let's collectively render a nice reasoned group analysis if this statement from the company sounds anything like a snake-oil salesman:
"In February 2022, the Company acquired US Patent rights to a process that increases dissolved oxygen in water. The process produces MorO2, ingestion of which is believed to increase diffusion of oxygen into muscle tissues. The Company is developing a business plan to manufacture and market products based on the MorO2 technology."
So, we have water, the building block of life. It's been around since the dawn of man. And this company purchased a patent on "better water" which is "believed" to increase oxygen diffusion in muscle tissues. No peer review, no science, just a process to make original water into fancy water. Something to make every human thrive. Not a sound investment for me, but I do enjoy a good conversation about a public company that gets regular folks to push its stock on public boards. Fascinating!
Just for sh$ and giggles, companies have been selling oxygenated water for some time now with no "superhumans" created yet:
https://www.mcgill.ca/oss/article/health-and-nutrition-you-asked/there-any-point-drinking-oxygenated-water
There's also hydrogenated water which "works" about the same:
https://www.healthline.com/nutrition/hydrogen-water
The interwebs is a glorious place. Happy Trading!!
Folks should know by now that the public filings prove the truth. EAC is going to be delisted from Nasdaq. They had until October 3 to meet the compliance deadline and failed. Just a matter of time.
EAC kicked the can on the merger down the road again. Filing is there for anyone to read.
EAC filed yet another registration statement with another special meeting upcoming which will lead to even more redemptions. Colbeck converted 6.9m Class B shares to Class A shares to massively dilute EAC. No one follows or cares about that SPAC so the price remains unchanged above $10/share. Anyone who reads the EAC financials knows the true value of EAC is way less based on the money actually held in trust and the correct number of outstanding shares.
"On July 20, 2023, Edify made a cash contribution of $225,000 to the trust account for the Initial Extension. In addition, the stockholders elected to redeem an aggregate of 697,235 shares of Edify’s Class A common stock in connection with the Second Charter Amendment. As a result, an aggregate of $7,488,538.44 (or approximately $10.74 per share) was removed from the trust account to pay such stockholders and 990,429 shares of Edify’s Class A common stock were then issued and outstanding following such redemption. As of [•], 2023, there was approximately $[•] held in the trust account."
The sharp downturn in UNQL revenues and business forecasts was also addressed in the EAC registration statement for anyone to read:
"In connection with its consideration of the Transactions, Unique Logistics provided the Original Projections, which included its internally prepared projections for the fiscal years ending May 31, 2023 and May 31, 2024, in connection with Edify’s evaluation of Unique Logistics. Unique Logistics believed that the forecasts and assumptions described above were reasonable at the time the Original Projections were prepared, given the information Unique Logistics had at that time and its business strategy and performance trends at such time. However, since the signing of the Merger Agreement in December 2022, certain unanticipated factors have arisen with the passage of time that have impacted Unique Logistics’ actual results to date in calendar 2023 and that are expected to continue to affect Unique Logistics’ results going forward. Those factors include (i) sharp decreases in market prices for ocean and air freight and (ii) decreases in freight market volumes due to the economic slowdown and an increase in customer inventories. As a result, Unique Logistics prepared new projections, as set forth under “— The Updated Projections” below, to reflect the adjusted assumptions and expectations of Unique Logistics’ management regarding Unique Logistics for the years ending May 31, 2023 and May 31, 2024. Accordingly, the Original Projections do not reflect Unique Logistics’ management’s view on future performance, and we caution you not to place undue reliance on the Original Projections in making a decision regarding the Transactions."
Anyone can read the updated projections:
"Updated Revenue Projections. Unique Logistics’ management decreased total revenue projections for 2024 by $370 million, from $791 million in the Original Projections to $421 million in the Updated Projections, mainly attributable to a decrease in spot rates for ocean and air freight. This decline is primarily due to an excess of shipping capacity and customer inventory overhang from the supply chain disruptions resulting from the COVID-19 pandemic."
"Updated Gross Profit Projections. Unique Logistics’ management decreased its gross profit projections for 2024 by $19 million, from $86 million in the Original Projections to $67 million in the Updated Projections. These adjustments were driven primarily by the lower shipping volume described above with respect to revenue."
"Updated Adjusted EBITDA Projections. Unique Logistics’ management decreased its Adjusted EBITDA projections for 2024 by $19 million, from $49 million in the Original Projections to $30 million in the Updated Projections. These adjustments were driven primarily by the factors described above, which decreased projected revenue and gross profit."
When this type of public information is provided, it really should be no surprise that UNQL reported a dismal Q1 with negative net profits and even negative adjusted EBITDA. The numbers don't lie......just folks who don't read the financials.
Quarterly Report out:
https://www.otcmarkets.com/filing/html?id=17000430&guid=qZ5-kWUojSxPB3h#FORM10-Q_HTM_a_003
$2.3m loss for the first quarter. Revenues down significantly and this is with the new Asian Offices. Lead Balloon earnings report but some will undoubtedly find silver linings.
I read the financials. They have no money. They make no money. They are a poop in one hand and wish for money in the other hand to see which fills first company. Debt. Offerings. Pumps. Dumps. Rinse. Repeat.
I had a crazy aunt who dated a guy from Amgen 20 years ago and they were going to be gazillionaires because he developed doggie sunscreen to prevent doggie cancer. Anyone want to guess how that turned out????
Bloody Friday Prediction. Wasn't this just at .004 and going to pennies on the way to dimes on the way to da mooooooonnnnnnn???
Company announced more dilution but folks swear no big deal.
Spinoffs....Mergers.....Acquisitions.....News.....Big Things Coming.....Lions.....Tigers....and......C'mon, you know......
Friday Bloody Friday.....in October....
Everyone knows your holdings since well above 20 cents because you posted them many times. This updated registration statement from EAC explains the MASSIVE dilution that will occur if that merger closes. I've explained it many times and this document says exactly what I explained. 28.2 million shares of UNQL which means ALL of the 9 BILLION preferred shares shall convert on this deal. MASSIVE DILUTION:
https://www.otcmarkets.com/filing/html?id=16987955&guid=nO5-knKWhGQlB3h#FS42023A1_EDIFYACQ_HTM_T992
Just MM shenanigans. Bid/Ask spreads of .0086 and .012 are not normal. That's like a bid/ask between $86 and $120. Someone got caught near .015 with an open market order. Anyone want to predict whether UNQL files the 10Q timely???
One needs to check the entire landscape to understand the utter BS of folks who post about BDPT (and similar) scams:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171977189
Friendly observation from a casual observer. BDPT was a pump and dump pinky. No need to argue with anyone. Check the chart, the filings, the dilution. If only it was possible to short on the OTC.....oh, wait......
A new 8K, extending loan terms again. Kicking the can down the road which is par for the course for UNQL:
https://www.otcmarkets.com/filing/html?id=16978968&guid=RJ5-kFxAigOCJth
Volume has shriveled again.
Savvy....
There are a handful of factors that converge from time to time to make a trading strategy play out with great probability. Thank you very much BDPT factors. Much appreciated!
Yesterday was the deadline for EAC to trade above $35m market cap for 10 consecutive days. They have been around $18m market cap for the entire time the compliance letter has been outstanding. Here is the prior 8K and the text:
https://www.otcmarkets.com/filing/html?id=16548293&guid=d25-k6fOuPdfJth
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
"On April 4, 2023, Edify Acquisition Corp. (the “Company”) received a letter (the “MVLS Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the MVLS Notice, the Company’s Minimum Market Value of Listed Securities (“MVLS”) was less than $35.0 million, which does not meet the requirement for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Staff has provided the Company with 180 calendar days, or until October 3, 2023, to regain compliance with the MVLS Rule. The MVLS Notice has no immediate effect on the listing of the Company’s securities on The Nasdaq Capital Market.
If the Company regains compliance with the MVLS Rule, the Staff will provide written confirmation to the Company and close the matter. To regain compliance with the MVLS Rule, the Company’s MVLS must meet or exceed $35.0 million for a minimum of ten consecutive business days during the 180-day compliance period ending on October 3, 2023. In the event the Company does not regain compliance with the MVLS Rule prior to the expiration of the compliance period, it will receive written notification that its securities are subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel.
The Company will continue to monitor its MVLS and consider its available options to regain compliance with the MVLS Rule. However, there can be no assurance that the Company will be able to regain compliance with the MVLS Rule."
It's just a matter of time until EAC is delisted from Nasdaq. Leave it to UNQL to reverse merge into another penny stock on the OTC. Savvy.......
For anyone still following the EAC merger, that shell filed an 8K the other day to notify that those 6.9m founders shares that were purchased for $25,000 are now converted from Class B to Class A shares. The new EAC Outstanding Share count is now 7,890,429. This has two important implications:
https://www.otcmarkets.com/filing/html?id=16964482&guid=d25-k6fOuPdfJth
1. Prior to this conversion, there were only 990,429 shares of EAC stock left after all of the redemptions. Remember, those were actually purchased by original investors in the blank check SPAC for $10/share, which now corresponds to around $10m in the EAC trust account.
2. The added 6.9m shares to the OS did not add $69m to the EAC trust account. Again, those were originally purchased by Colbeck for just $25,000.
For anyone interested in shorting, EAC stock is a prime candidate. The market has not digested this information yet and EAC currently trades at $10.85. However, simple math suggests the stock is worth much less. $10,000,000 divided by 7,890,429 shares = $1.27/share. Happy trading!
Traditionally with this stock, those short reports are indications of large block institutional transactions. Essentially, a large shareholder is slowly liquidating and the MMs are creating these large bid/ask spread games so the price does not plummet during the controlled sale. At the same time, yahoos come on these boards and claim they are making a killing as the 1 or 2 people in the world who consistently buy low and sell high. It's just not accurate or credible, but fun to read. One dude has confirmed huge bags he bought at 20 cents and above when you look at the post history, but somehow keeps bragging after the fact (mind you, only during a week when the price goes up, never when the price is trending down) that he was the one killing it all week. Equal parts funny and sad. Have a great weekend!
UNQL and EAC extended the merger deadline again to May 15, 2024. That is 16 months after EAC was originally supposed to close a merger. For reference, UNQL closed the reverse merger into the Innocap shell just days after the merger announcement and the ticker changed 3 months later. EAC is an empty shell and there's nothing to combine. Such a farce. EAC will be delisted from Nasdaq next month.
Of course I will be labeled a basher, but the public financials tell the story of a 'move the pea under the shell game' company that exists on debt. Here is the key number to evaluate....operating income. That is the most basic reading of the health of a business. How much money does it generate from operations when you subtract costs from revenues. For UNQL last year, that was $10.5m. For comparison, it was $16.5m the year before. This means the real world fact is that they made 40% less money from operations.
So, why was there an $8.2m net income this year compared to a $1m loss last year? It's all in how they move things around in the books. They took on a huge debt with the Asian Offices merger. $28m purchase price. That is real money, some of which they paid, and most of it is still financed on the books to be repaid with significant interest.
How much? They still owe $15m. That's a lot of money when the company only makes $10.5m from operations. The company will still operate, but there's nothing being generated for the shareholders. Just debt and interest payments.
To make this debt situation look pretty on the balance sheet, they add in an enormous new goodwill number to reflect their valuation of what they purchased in Asia. And remember, they don't own it all yet. They are financing it. It's like "owning" a million dollar house with a $750k mortgage. Folks say they have a million dollar asset based on the FMV of the home, but in reality they only own $250k of that house upon sale, less commissions and fees.
Same with UNQL. They are claiming $16m as a new goodwill asset for Asia, raising the total goodwill asset to $20.5m on the books. The Asian revenues are significantly less than US operations, but counted as 4 times more in goodwill added to the books??? This is the shell game accounting for folks to understand. That goodwill line on the balance sheet is not real money in the bank account. It's something a company hopes a purchaser buys if there is a company sale, but it represents nothing going to shareholders if there is a liquidation. It's just an added "asset" on the books like the asset of a home. But you can't ignore the mortgage or the debt in the case of UNQL. $20.5m goodwill value with $15m of debt still owed for Asia. See how the $6m market cap is about right?
Then, when you compare that new $16m goodwill asset to the net profit of $8.2m.....uh-oh. UNQL shows current stockholders equity of $17.5m. However, that includes that $20.5m in goodwill plus another $13m in intangible assets. Intangible meaning there is no real money to pay shareholders upon liquidation. They added $5.5m in intangible assets to the books this year. That amounts to $21.5m worth of "new money assets" added to the books this year which are nothing more than goodwill and intangible assets. Without that funny money added to the Balance Sheet, UNQL would have negative $4m stockholders equity instead of positive $17.5m currently reported.
Valuing a company and it's stock price takes more analysis than one number. The company has massive debt and pays millions in interest payments each year. They live on debt, paycheck to paycheck like most Americans. Nothing wrong with that. But recognize them for what they are.
TBK Bank does. They see the declining revenues, and know about the upcoming debt payments. That's why TBK reduced the invoice credit facility nearly in half from $47.5m to $25m for the next fiscal year:
"In addition, the Company maintains its operating line of credit with TBK Bank, SSB, under which TBK Bank will, from time to time, buy approved receivables from Unique Logistics, that has a credit limit up to $47.5 million (“TBK Facility”). The prior TBK Facility matured on May 31, 2023, and on July 25, 2023 we entered into an agreement with TBK Bank to renew the TBK Facility with a credit limit of up to $25.0 million. We believe that the funds available under the current TBK Facility, together with cash flows generated by operating activities, will provide the Company with the cash required to support its ongoing operations."
All of this information is out there for public consumption. Be careful what you hear from internet trolls on public message boards.
How is your 10 cent average bag doing? You posted all your buys in the teens and 20s. Do we need to go through the exercise of what a complete full of crap liar you are again?
You obviously didn't buy more on this news. Low volume like usual. Funny how you are the only one who buys low and sells high on UNQL. No other players in the market. Just you, you, you, you.
Do your thing. Get your crew. Pump this puppy. $8.2m profit. Just be sure to turn a blond eye to the exact $8.2m the company added as a goodwill "asset" for the Asian Offices they purchased from themselves for $35m. Please, don't forget that tiny detail in your pumper shell game. Because without that new goodwill asset and the other $8m intangible asset they mysteriously added to the books, it would have been another net loser year. Good thing for creative accounting and pumpers like you. Suckers born every day.
The annual report is finally out 2 weeks late.
https://www.otcmarkets.com/filing/html?id=16931617&guid=Xig-kp5kxDnKJth
Some key takeaways:
"Unique Logistics expects to incur significant costs associated with the Merger. Even if we do not complete the Merger, we expect to incur approximately $8.2 million in expenses, $1.1 million of which we have incurred to date. These expenses will reduce the amount of cash that we have available for other corporate purposes regardless of whether if we complete the Merger. Further, the completion of the Merger depends on the satisfaction of specified conditions, including the requisite approval of Edify’s stockholders and that Edify hold net tangible assets of at least $5,000,001 immediately prior to the closing of the Transactions, net of Edify’s redemption of any shares of its Class A common stock. There is no guarantee that these conditions will be met. If the Merger is not completed, these expenses could have a material adverse impact on our financial condition because we would not have realized the expected benefits for which these expenses were incurred."
Wow, $8.2m in wasted expenses if the EAC merger fails.
"Market conditions trended towards a slowdown in shipping in fiscal 2023. This slowdown significantly impacted Unique Logistics in the year ended May 31, 2023. The impact was particularly severe in the air freight sector. The uncertainty created by inflation and high inventory levels coupled with the fact that Unique Logistics’ third fiscal quarter is traditionally a slow period due to shipping market seasonality, has resulted in lower shipping volumes and lower shipping costs. Lower shipping costs result in lower revenue for Unique Logistics. We believe, however, that Unique Logistics is positioned to improve net revenue yield through improved procurement; we have also added to our customer base in the last 15 months, which will mitigate the impact of a declining shipping market."
Declining revenues but always optimistic to turn things around. Ok.
"During the year ended May 31, 2022, Unique Logistics experienced not just a surge in volume but due to the elevated cost of shipping, revenues increased tremendously, while net revenue or gross profit as a percentage of gross revenue declined. In the year ended May 31, 2023, by comparison, volumes declined and per unit revenue declined due to lower shipping costs and, correspondingly, the rates we charged our customers."
That quote is for all those lying pumpers who relentlessly screamed a billion in revenues and to da mooooon, LOL. It was the biggest boom in shipping but they couldn't capitalize on profits. Oh well.
Just $325m total revenues this fiscal year compared to $1b last year. 68% drop. Can't wait to hear the spin artists tackle that one.
They increased gross margins, Woo-hoo! Net income was $8.2m but.....wait for it..... paid $3.8m in interest and still carries over $15m in debt (not counting that $8.2m in EAC merger expenses.) They also count $20m as goodwill and another $12m as intangible assets which cook the books a bit and won't be available as real money if there is a liquidation. Something real investors consider. Again, the spin doctors can have their way with those numbers. I'm personally happy UNQL was able to increase net profits. Great job!! They do have A LOT of debts and pending expenses with declining revenues, so it's prudent to be cautious, especially with $32m in ethereal "assets".
The market hasn't reacted yet with only 58k share volume. Those Asian Offices aren't adding the punch many were hoping for. Good Luck out there!